Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Christopher Gray is active.

Publication


Featured researches published by Christopher Gray.


Electrophoresis | 2000

Two-dimensional map of the proteome of Haemophilus influenzae

Hanno Langen; Béla Takács; Stefan Evers; Peter Berndt; Hans-Werner Lahm; Beat Wipf; Christopher Gray; Michael Fountoulakis

We have constructed a two‐dimensional database of the proteome of Haemophilus influenzae, a bacterium of medical interest of which the complete genome, comprising about 1742 open reading frames, has been sequenced. The soluble protein fraction of the microorganism was analyzed by two‐dimensional electrophoresis, using immobilized pH gradient strips of various pH regions, gels with different acrylamide concentrations and buffers with different trailing ions. In order to visualize low‐copy‐number gene products, we employed a series of protein extraction and sample application approaches and several chromatographic steps, including heparin chromatography, chromatofocusing and hydrophobic interaction chromatography. We have also analyzed the cell envelope‐bound protein fraction using either immobilized pH gradient strips or a two‐detergent system with a cationic detergent in the first and an anionic detergent in the second‐dimensional separation. Different proteins (502) were identified by matrix‐assisted laser desorption/ionization mass spectrometry and amino acid composition analysis. This is at present one of the largest two‐dimensional proteome databases.


Expert Opinion on Investigational Drugs | 1998

The microbial postgenomic era: promises, problems and prospects.

Christopher Gray; Wolfgang Keck

The inevitable emergence and spread of resistance to new antibiotics entering the market necessitates a new approach in drug discovery. Novel classes of antimicrobial compounds are required that are not enfeebled by widespread resistance mechanisms. The favoured approach is to gain a better understanding of the essential pathways and cellular functions and then to select new unexploited targets. This strategy has coincided with the deposition of fully assembled genomic sequences of several bacteria in the public databases. Various technologies have been reported that, when optimised, will enable the analysis of global cellular processes at the molecular level thus greatly contributing to our understanding of cellular physiology. In this article, some of the major advances in technology, which are expected in the future to be essential for the optimal use of the information contained within the genomic sequences, will be outlined.


Nature Genetics | 1999

Genome-wide transcriptional analysis of bacterial genomes: applications in antibacterial drug discovery

Antoine de Saizieu; Hans Gmuender; Christopher Gray; Wolfgang Keck

An oligonucleotide array of more than 250,000 specific probes representing two complete bacterial genomes including the 1,743 open reading frames of Haemophilus influenzae, and the 1,969 open reading frames of Streptococcus pneumoniae has been designed. When hybridised against labelled genomic DNA, all genes were detected and more than 96% of the signal intensity values were within a factor of three of the mean. For transcript imaging, microarrays were hybridised against total RNA populations quantitatively represented by labelled cDNAs. The measurements of transcript abundance for all genes were shown to be sensitive, specific, quantitative and reproducible. Nearly 85% of all S. pneumoniae mRNAs were found expressed during in vitro exponential growth. Identification of regulons important for S. pneumoniae entry into the stationary phase has been used to validate the approach. We will show, for the first time, how a genome-wide transcriptional analysis is applied to bacterial genomes and is being used to identify signal transduction regulatory networks, and to profile antibiotic compounds.


Genome Research | 2001

Gene Expression Changes Triggered by Exposure of Haemophilus influenzae to Novobiocin or Ciprofloxacin: Combined Transcription and Translation Analysis

Hans Gmuender; Karin Kuratli; Karin Di Padova; Christopher Gray; Wolfgang Keck; Stefan Evers


Electrophoresis | 1997

Two‐dimensional map of Haemophilus influenzae following protein enrichment by heparin chromatography

Michael Fountoulakis; Hanno Langen; Stefan Evers; Christopher Gray; Béla Takács


Journal of Chromatography A | 1998

Enrichment and purification of proteins of Haemophilus influenzae by chromatofocusing

Michael Fountoulakis; Hanno Langen; Christopher Gray; Béla Takács


Electrophoresis | 1997

FROM GENOME TO PROTEOME: PROTEIN MAP OF HAEMOPHILUS INFLUENZAE

Hanno Langen; Christopher Gray; Daniel Röder; Jean-François Juranville; Béla Takács; Michael Fountoulakis


Proteomics | 2001

Mechanism-related changes in the gene transcription and protein synthesis patterns of Haemophilus influenzae after treatment with transcriptional and translational inhibitors.

Stefan Evers; Karin Di Padova; Michelle Meyer; Hanno Langen; Michael Fountoulakis; Wolfgang Keck; Christopher Gray


Journal of Molecular Biology | 1999

THE STRUCTURE AND FUNCTION OF THE 6-HYDROXYMETHYL-7,8-DIHYDROPTERIN PYROPHOSPHOKINASE FROM HAEMOPHILUS INFLUENZAE

Michael Hennig; Glenn E. Dale; Allan D'Arcy; Franck Danel; Stefan Fischer; Christopher Gray; Synese Jolidon; Francis Müller; Malcolm G. P. Page; P. Pattison; Christian Oefner


Briefings in Bioinformatics | 2000

Visualising gene expression in its metabolic context

Detlef Wolf; Christopher Gray; Antoine de Saizieu

Collaboration


Dive into the Christopher Gray's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge